The first ELRIG meeting on Advances in Cell and Gene Therapies will be held virtually on the 18th and 19th of May 2021. This interactive 2-day conference will host world-leading scientists from academia and industry to discuss current and future perspectives of Cell and Gene Therapies.
Cell and gene therapies are rapidly evolving at a fast pace, revealing many new and exciting therapeutic opportunities not previously amenable to drug discovery. The aim to bring together scientists from academia, pharma, biotech, and CRO’s to engage with speakers at the cutting edge of developing and applying cell and gene therapies.
The event will help participants develop a better understanding of the field and provide networking opportunities with a range of key experts. The aim is to create an open and inspiring environment that will foster discussions and the identification of opportunities for collaboration with a scientific program developed around three key focus areas:
- Cell-based therapies across disease areas
- Advanced therapies in oncology
- Therapies for genetic conditions
Mogrify® has developed a proprietary suite of platform that utilize a systematic big-data approach to direct cellular conversion (Rackham et al., Nature Genetics, 2016) and the maintenance of cell identity (Kamaraj et al., Cell Systems 2020). Mogrify is applying its proprietary and award-winning platforms to engineer a renewable and scalable source of cell types that exhibit efficacy and safety profiles necessary to transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies for indications of high unmet clinical need in hematological, immunological, ophthalmological and other disease areas.